An open-label phase 2 trial to assess the efficacy, safety and pharmacokinetics of lanthanum carbonate in hyperphosphatemic children and adolescents with chronic kidney disease undergoing dialysis

Wasilewska, AnnaMurray, Rose AnnSundberg, AimeeUddin, SharifAchenbach, HeinrichShavkin, AlekseySzabó, TamásVergani, AndreaUmeh, Obi2022-03-312022-03-312022BMC Nephrology. -23 : 1 (2022), p. 1-15. -BMC Nephrol. - 1471-23691471-2369http://hdl.handle.net/2437/329697An open-label phase 2 trial to assess the efficacy, safety and pharmacokinetics of lanthanum carbonate in hyperphosphatemic children and adolescents with chronic kidney disease undergoing dialysisfolyóiratcikkopen access journalhttps://ebib.lib.unideb.hu/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM101164OrvostudományokKlinikai orvostudományokhttps://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-022-02688-9http://dx.doi.org/10.1186/s12882-022-02688-92022-04-2200076340080000185125611756